American Healthcare REIT, Inc. · REIT (real estate trust)

AHR

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 24% in the latest quarter vs a year ago
Profitable
Brings in more cash than it spends

Watch out for

Share count growing 36.4% a year (dilution)
2 offering filings in 6 months (may sell new shares)

Money moves

No insider buying or selling in the last 30 days
Institutions added 19% to their holdings in the quarter ending June 2026 (329 bought, 202 sold)
Held by George Soros (Soros Fund)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$53.56+1.0% that day

Company value: $11.7B; Share price times all shares
Price vs profit (P/E): 78.8x; You pay about $79 for each $1 of yearly profit
Price vs sales: 4.7x; Company value is 4.7 times a year of sales
Dividend yield: 1.9%; Yearly dividend as a share of today's price
Cash vs value: 1%; Cash as a share of company value
Debt vs value: 8%; Debt as a share of company value

From AHR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$674.3M+24% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $2.5B, up 16% from the 12 months before. Over 5 years, sales grew about 16% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of AHR. Starting points are the company's recent numbers.

Sales growth+16% a yearRecently: +16% a yearProfit margin5%Last 12 months: 4.9%P/E at the end40xToday: 78.8x. Many steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$5.3B

Profit in 5 years$263M

Price these guesses point to$29.94-44% vs $53.56 todayAbout -11% a year, before dividends

What today's price needs: with a 5% margin and a 40x P/E, sales would have to grow about 30% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.2.5%
PassDebt under half of equityNot relying on borrowed money.0.29x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.3.1%
MissProfitable every yearSteady profits, not one good year.3 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$294.4M
MissShare count not growingNot diluting owners. Falling means buybacks.+153.5% in 3 years

Revenue: $2.3B; +9.1% vs prior year
5-year growth: +16.2%/yr; revenue, per year
Total debt: $966.9M; 0.29x equity
Free cash flow: $294.4M; 13.0% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 6

Revenue: $674.3M; +24.3% YoY
EPS: $0.16; vs $0.06
Op. margin: 20.4%; +1.4 pts
Gross margin: 22.2%; +0.8 pts
Free cash flow: $118.6M
Share count: +20.0%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.5
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+19.3%

Institutions added 19.3% to their holdings. 329 bought, 202 sold. 7 quarters of net buying in a row.

Shares held by institutions224.8M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+36.4%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.2x · $873.4M debt

Shares outstandingLatest reported

218M

Earnings reports

Last 10

Next reportAround Nov 5 (est.)Estimated from the same quarter last year

Results filedAug 6
Results filedMay 7
Results filedFeb 26
Results filedNov 6, 2025
Results filedAug 7, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Offering prospectusAug 11 · View filing ↗Offering Offering prospectusAug 10 · View filing ↗Offering New 5%+ holder (passive)Aug 7 · View filing ↗Big holder Offering prospectusMay 21 · View filing ↗Offering Offering prospectusMay 20 · View filing ↗Offering

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

New insiderOct 2 · Form 3 ↗

SoldMark E. FosterEVP, GC & Secretary

1,500 shares at $52.06 · $78K

-3% of holdings
Now owns 50,117 shares
Not a pre-planned sale
Filed 3 days after trade

Sep 25Form 4 ↗

Planned insider saleSep 25 · Form 144 ↗Investor disclosureSep 18 · Form 8-K ↗Investor disclosureSep 14 · Form 8-K ↗Leadership changeSep 2 · Form 8-K ↗Investor disclosureSep 1 · Form 8-K ↗Planned insider saleSep 1 · Form 144 ↗

SoldMark E. FosterEVP, GC & Secretary

2,000 shares at $55.39 · $111K

-4% of holdings
Now owns 51,617 shares
Pre-planned sale (10b5-1)
Filed same day

Sep 1Form 4 ↗

Other company newsAug 24 · Form 8-K ↗Other company newsAug 12 · Form 8-K ↗Offering prospectusAug 11 · Form 424B5 ↗Major agreementAug 10 · Form 8-K ↗Offering prospectusAug 10 · Form 424B5 ↗New 5%+ holder (passive)Aug 7 · Form SCHEDULE 13G ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page